MAMOME INC.
MAMOME INC. is a biotechnology company founded in 2019, specializing in microbiome research and maternal health. Based in New York, the company develops non-invasive diagnostic tools for early detection of gestational diabetes and offers nutritional education and support for expectant mothers.
Company Overview
MAMOME INC. is a biotechnology company founded in 2019, headquartered in New York, US. With a team size of 8, it operates as a very small business. The company specializes in microbiome research and its applications in maternal health, particularly focusing on gestational diabetes. MAMOME INC. integrates artificial intelligence and machine learning into its operations, emphasizing diagnostics and molecular biology to enhance maternal and infant health outcomes.
Services
MAMOME INC. provides a range of services aimed at improving maternal health. It offers nutritional education on diets that promote a healthy microbiome, which is essential for both maternal and infant health. The company develops at-home fecal microbiome tests for the early detection of gestational diabetes, providing a convenient and non-invasive option for expectant mothers. Additionally, it connects women’s health clinics with registered dietitians through a digital platform, facilitating enhanced patient care.
Products
The company has developed several innovative products, including a microbiome analysis test that assesses the diversity and balance of the microbiome, specifically focusing on bacteria that impact pregnancy outcomes. MAMOME INC. also offers a simple at-home test kit for microbiome analysis, which does not require appointments. Its proprietary technology for at-home fecal microbiome tests targets early detection of gestational diabetes, utilizing advanced bioinformatics and next-generation DNA sequencing.
Research and Development
MAMOME INC. engages in clinical research to discover biomarkers that predict the likelihood of developing gestational diabetes during the first trimester of pregnancy. The company conducts studies aimed at improving birth outcomes and reducing maternal deaths through early nutrition and microbiome interventions. It also partners with clinics to utilize existing billing codes from Medicaid and private insurance, ensuring the profitability of its services while enhancing patient access to care.
Patient Support
MAMOME INC. supports patients throughout their pregnancy journey, from sample collection to understanding test results. The company offers comprehensive care from pre-pregnancy through the baby's first year, including weight management and support for high-risk conditions. It provides 24/7 access to a HIPAA-secure telehealth platform for nutrition support and education, ensuring that patients receive continuous guidance and assistance during their pregnancy.